InvestorsHub Logo
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Wednesday, 05/01/2019 9:46:04 AM

Wednesday, May 01, 2019 9:46:04 AM

Post# of 4159
$TLTFF "clinical study for a new cancer indication.”

Theralase® Patient Five Cancer-Free Twelve Months After Single Anti-Cancer Treatment January 31, 2019

"Pending successful commencement of the Phase II NMIBC clinical study, the Company plans to investigate the commencement of an additional Phase Ib clinical study for a new cancer indication.”

The guidance was clear from January.
________________________________

Theralase Commences Phase II NMIBC Clinical Study
April 25, 2019

http://theralase.com/press-releases/

JMO, maybe, maybe not.